预防住院患者肺栓塞。
Prevention of pulmonary emboli in hospitalized patients.
出版信息
Can Fam Physician. 1983 Feb;29:321-4.
Abstract
The risk of pulmonary infarction in any hospitalized population is high. To decrease this dreaded complication, the high risk population must be identified. These are chiefly elderly patients with a history of previous DVTP, cancer, cardiac disease, trauma to a lower limb or a history of recent surgery. All methods of reducing venous stasis should be used, and most of these patients should be treated prophylactically with subcutaneous heparin.
摘要
任何住院人群的肺梗死风险都很高。为了降低这种可怕的并发症，必须识别高危人群。这些主要是有先前深静脉血栓形成史、癌症、心脏病、下肢创伤或近期手术史的老年患者。应使用所有减少静脉淤滞的方法，大多数此类患者应预防性皮下注射肝素。
相似文献
1
Prevention of pulmonary emboli in hospitalized patients.
Can Fam Physician. 1983 Feb;29:321-4.
2
Deep venous thrombosis and pulmonary emboli: etiology, medical treatment, and prophylaxis.
J Thorac Imaging. 1989 Oct;4(4):4-7. doi: 10.1097/00005382-198910000-00005.
3
Pulmonary embolism: incidence, diagnosis, prevention, and treatment.
J Am Osteopath Assoc. 1985 Mar;85(3):176-85.
4
[Epidemiology and etiopathogenesis of deep venous thrombosis of the lower limbs].
Agressologie. 1990 Mar;31(3):141-3.
5
A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium/dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery.
J Urol. 1991 Jun;145(6):1205-8. doi: 10.1016/s0022-5347(17)38576-2.
6
Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke.
Age Ageing. 1986 Mar;15(2):84-8. doi: 10.1093/ageing/15.2.84.
7
8
Current indications for preoperative inferior vena cava filter insertion in patients undergoing surgery for morbid obesity.
Obes Surg. 2005 Aug;15(7):1009-12. doi: 10.1381/0960892054621279.
9
DVT and pulmonary embolism: Part II. Treatment and prevention.
Am Fam Physician. 2004 Jun 15;69(12):2841-8.
本文引用的文献
1
Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment.
Am J Cardiol. 1959 Nov;4:611-21. doi: 10.1016/0002-9149(59)90145-6.
2
Some epidemiologic considerations of thromboembolism.
Surg Gynecol Obstet. 1959 Oct;109:487-501.
3
Thrombosis and oral contraception.
Br J Hosp Med. 1980 Nov;24(5):438-40, 442.
4
Simple mechanical method for decreasing the incidence of thromboembolism.
Am J Surg. 1981 May;141(5):582-5. doi: 10.1016/0002-9610(81)90056-8.
5
The effect of dihydroergotamine and heparin on the incidence of thromboembolic complications following total hip replacement: a randomized controlled clinical trial.
Br J Surg. 1981 May;68(5):301-3. doi: 10.1002/bjs.1800680503.
6
A comparative study of Dextran 70 and a sulphated polysaccharide in the prevention of postoperative thromboembolic complications.
Br J Surg. 1981 Jul;68(7):449-51. doi: 10.1002/bjs.1800680702.
7
The prevention of thromboembolic disease by prophylactic anticoagulation. A controlled study in elective hip surgery.
J Bone Joint Surg Am. 1967 Jan;49(1):81-9.
8
Neuro-ophthalmic sequelae in users of oral contraceptives.
JAMA. 1968 Sep 30;206(1):85-91.
9
Oral contraceptives and thromboembolic disease.
JAMA. 1968 Sep 30;206(1):77-84.
10
Investigation of relation between use of oral contraceptives and thromboembolic disease.
Br Med J. 1968 Apr 27;2(5599):199-205. doi: 10.1136/bmj.2.5599.199.
Zotero 插件